Exicure (XCUR) Cash & Current Investments (2016 - 2026)
Exicure (XCUR) reported Cash & Current Investments of $2.6 million for Q1 2026, down 75.01% on a YoY basis from $10.4 million in Q1 2025, and down 30.49% quarter-over-quarter from $3.7 million in Q4 2025.
Exicure (XCUR) Cash & Current Investments (2016 - 2026) Analysis & Trends
Exicure has reported Cash & Current Investments for 11 years, with the latest figure at $2.6 million in Q1 2026.
- For the quarter ending Q1 2026, Cash & Current Investments fell 75.01% year-over-year to $2.6 million; the trailing twelve-month figure through Mar 2026 stood at $2.6 million (down 75.01% YoY), and the FY2025 full-year result was $3.7 million, down 70.05% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $2.6 million, down from $3.7 million in the prior quarter.
- The five-year high for Cash & Current Investments was $26.4 million in Q1 2022, with the low at $343000.0 in Q3 2024.
- Historically, Cash & Current Investments has averaged $7.8 million across 5 years, with a median of $4.4 million in 2025.
- Annual changes were most pronounced in 2024 — Cash & Current Investments plunged 96.33% — and 2025, when it soared 2746.99%.
- Exicure's Cash & Current Investments stood at $9.8 million in 2022, then sank by 79.38% to $2.0 million in 2023, then jumped by 520.44% to $12.5 million in 2024, then plunged by 70.05% to $3.7 million in 2025, then plunged by 30.49% to $2.6 million in 2026.
- The last three Cash & Current Investments figures came in at $2.6 million (Q1 2026), $3.7 million (Q4 2025), and $4.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 32.30 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 2.13 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 286.70 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 2.77 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 18.44 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 7.20 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 7.25 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | 2.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.60 Mn |
| Dec 31, 2025 | 3.75 Mn |
| Sep 30, 2025 | 4.44 Mn |
| Jun 30, 2025 | 7.86 Mn |
| Mar 31, 2025 | 10.42 Mn |
| Dec 31, 2024 | 12.51 Mn |
| Sep 30, 2024 | 343,000.00 |
| Jun 30, 2024 | 528,000.00 |
| Mar 31, 2024 | 366,000.00 |
| Dec 31, 2023 | 2.02 Mn |
| Sep 30, 2023 | 922,000.00 |
| Jun 30, 2023 | 2.34 Mn |
| Mar 31, 2023 | 9.96 Mn |
| Dec 31, 2022 | 9.78 Mn |
| Sep 30, 2022 | 15.65 Mn |
| Jun 30, 2022 | 22.20 Mn |
| Mar 31, 2022 | 26.38 Mn |
| Dec 31, 2021 | 39.14 Mn |
| Sep 30, 2021 | 60.84 Mn |
| Jun 30, 2021 | 56.06 Mn |